Status:

RECRUITING

Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task

Lead Sponsor:

Indiana University

Conditions:

Motor Activity

Eligibility:

All Genders

18-45 years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether "transcranial direct current stimulation" (tDCS) is effective in enhancing learning of complex motor tasks of precision and accuracy that require the ...

Eligibility Criteria

Inclusion

  • Between ages 18 and 45 years old (to avoid any changes in the developing brain, or with aging).
  • Answer 'no' to questions 2 through 16 on the tDCS checklist as these factors can increase likelihood of adverse events with tDCS
  • No neurological damage, disease, or dysfunction (nerve damage, chronic pain disorders, diabetic neuropathy) that affect the upper limbs.
  • No significant acute or chronic medical, neurologic, or illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study

Exclusion

  • • Currently prescribed and taking stimulant medication (Adderall, Ritalin, Vyvanse, etc.)
  • Consumption of over-the-counter stimulants such as caffeine or nicotine (coffee, soda, supplements, energy drinks, tobacco products, or other nicotine containing products such as gum, vape pens, etc...) 12 hours prior to entering the lab on the day of testing as this can directly affect cortical excitability. If a subject takes any of these substances 12 hours prior to session 1 they will be asked to reschedule for a later date.
  • Have played a real stringed instrument in the last 12 months (e.g. guitar, bass, violin)
  • Have played the videogame "Guitar Hero" on a traditional guitar controller in the last 12 months.

Key Trial Info

Start Date :

March 3 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 3 2026

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT07202702

Start Date

March 3 2025

End Date

March 3 2026

Last Update

October 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Institute for Fitness and Sport

Indianapolis, Indiana, United States, 46202